Targeting inflammation may help overcome drug resistance in colon cancer
May 21, 2026
May 21, 2026
ITHACA, New York, May 21 -- Cornell University posted the following news:
* * *
Targeting inflammation may help overcome drug resistance in colon cancer
*
Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.
According to a new preclinical study from Weill Cornell Medicine investigators, colorectal tumors often find multiple ways to survive treatment, including . . .
* * *
Targeting inflammation may help overcome drug resistance in colon cancer
*
Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.
According to a new preclinical study from Weill Cornell Medicine investigators, colorectal tumors often find multiple ways to survive treatment, including . . .